Earlier studies indicate that a combination of HDAC and DNMT inhibitors, alone or together with other therapies, reverse epigenetic alterations and inhibit growth of cancer cells in vitro25,26 and in patients with advanced cancer35–37. The gene discussed is HDAC9; the disease is cancer.